Hakan Yucel

Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer.

U. Demirci, Ozlem Dogan, A. Erdoğan, 2023, Future oncology.